Oscar Health(OSCR)
$26.17-1.40 (-5.08%)
OSCR
Oscar Health financials statements
$26.17
At close:-1.40 (-5.08%)
Want to see OSCR full AI Analyst Report?
Oscar Health (OSCR) Ratios
2,662 Followers
Oscar Health Ratios
OSCR's free cash flow for Q3 2026 was $-1.21B. For the 2026 fiscal year, OSCR's free cash flow was decreased by $-11.31M and operating cash flow was $-1.20B. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.95 | 0.90 | 0.00 | 1.26 | 0.00 |
| Quick Ratio | 0.95 | 0.90 | 0.00 | 1.26 | 0.00 |
| Cash Ratio | 0.57 | 0.48 | 0.00 | 0.48 | 0.00 |
| Solvency Ratio | -0.08 | 0.02 | -0.09 | -0.16 | -0.29 |
| Operating Cash Flow Ratio | 0.23 | 0.31 | 0.00 | 0.12 | 0.00 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | $ -731.27M | $ -978.90M | $ -2.80B | $ 487.35M | $ -1.93B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.07 | 0.06 | 0.08 | 0.07 | 0.00 |
| Debt-to-Equity Ratio | 0.44 | 0.30 | 0.37 | 0.33 | 0.00 |
| Debt-to-Capital Ratio | 0.31 | 0.23 | 0.27 | 0.25 | 0.00 |
| Long-Term Debt-to-Capital Ratio | 0.31 | 0.23 | 0.27 | 0.25 | 0.00 |
| Financial Leverage Ratio | 6.47 | 4.78 | 4.48 | 5.08 | 2.39 |
| Debt Service Coverage Ratio | -22.54 | 3.45 | -8.75 | -25.27 | -116.97 |
| Interest Coverage Ratio | -22.52 | 2.41 | -10.86 | -26.97 | -120.89 |
| Debt to Market Cap | 0.11 | 0.09 | 0.15 | 0.57 | 0.00 |
| Interest Debt Per Share | 1.71 | 1.34 | 1.46 | 1.51 | 0.03 |
| Net Debt to EBITDA | 5.99 | -13.75 | 7.41 | 2.20 | 2.00 |
| Profitability Margins | |||||
| Gross Profit Margin | 14.38% | 20.10% | 100.00% | 100.00% | 100.00% |
| EBIT Margin | -3.59% | 0.62% | -4.14% | -14.24% | -29.46% |
| EBITDA Margin | -3.34% | 0.97% | -3.62% | -13.87% | -28.70% |
| Operating Profit Margin | -3.39% | 0.62% | -4.56% | -14.79% | -29.70% |
| Pretax Profit Margin | -3.74% | 0.36% | -4.56% | -14.79% | -29.70% |
| Net Profit Margin | -3.79% | 0.28% | -4.62% | -14.70% | -29.81% |
| Continuous Operations Profit Margin | -3.79% | 0.28% | -4.62% | -14.77% | -29.75% |
| Net Income Per EBT | 101.34% | 76.08% | 101.28% | 99.38% | 100.36% |
| EBT Per EBIT | 110.33% | 58.37% | 100.00% | 100.00% | 100.00% |
| Return on Assets (ROA) | -7.01% | 0.53% | -7.52% | -13.39% | -17.24% |
| Return on Equity (ROE) | -45.33% | 2.51% | -33.67% | -68.09% | -41.28% |
| Return on Capital Employed (ROCE) | -27.10% | 3.43% | -7.42% | -48.32% | -17.18% |
| Return on Invested Capital (ROIC) | -27.10% | 2.68% | 0.00% | -48.27% | 0.00% |
| Return on Tangible Assets | -7.01% | 0.53% | -7.52% | -13.39% | -17.24% |
| Earnings Yield | -11.75% | 0.79% | -13.35% | -115.99% | -40.76% |
| Efficiency Ratios | |||||
| Receivables Turnover | 26.44 | 29.05 | 11.86 | 82.74 | 3.14 |
| Payables Turnover | -100.44 | 5.24 | 0.00 | 0.00 | 0.00 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 132.44 | 137.40 | 94.67 | 68.89 | 41.21 |
| Asset Turnover | 1.85 | 1.90 | 1.63 | 0.91 | 0.58 |
| Working Capital Turnover Ratio | -40.65 | 9.56 | 13.67 | 9.62 | 0.00 |
| Cash Conversion Cycle | 17.44 | -57.03 | 30.78 | 4.41 | 116.11 |
| Days of Sales Outstanding | 13.81 | 12.56 | 30.78 | 4.41 | 116.11 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | -3.63 | 69.59 | 0.00 | 0.00 | 0.00 |
| Operating Cycle | 13.81 | 12.56 | 30.78 | 4.41 | 116.11 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 4.17 | 4.07 | -1.23 | 1.79 | -1.02 |
| Free Cash Flow Per Share | 4.03 | 3.95 | -1.34 | 1.65 | -1.16 |
| Dividend Paid and CapEx Coverage Ratio | 30.10 | 35.06 | -10.64 | 13.11 | -7.02 |
| Capital Expenditure Coverage Ratio | 30.10 | 35.06 | -10.64 | 13.11 | -7.02 |
| Operating Cash Flow Coverage Ratio | 2.55 | 3.27 | -0.91 | 1.28 | 0.00 |
| Operating Cash Flow to Sales Ratio | 0.09 | 0.11 | -0.05 | 0.09 | -0.09 |
| Free Cash Flow Yield | 28.07% | 29.41% | -14.68% | 67.22% | -14.78% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -8.50 | 122.18 | -7.49 | -0.86 | -2.45 |
| Price-to-Sales (P/S) Ratio | 0.32 | 0.35 | 0.35 | 0.13 | 0.73 |
| Price-to-Book (P/B) Ratio | 3.86 | 3.19 | 2.52 | 0.59 | 1.01 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 3.56 | 3.40 | -6.81 | 1.49 | -6.77 |
| Price-to-Operating Cash Flow Ratio | 3.44 | 3.30 | -7.45 | 1.37 | -7.73 |
| Price-to-Earnings Growth (PEG) Ratio | 0.01 | -1.12 | 0.13 | 0.09 | -0.03 |
| Enterprise Value Multiple | -3.65 | 22.43 | -2.15 | 1.29 | -0.55 |
| Enterprise Value | 1.43B | 2.00B | 456.61M | -737.91M | 300.90M |
| EV to EBITDA | -3.65 | 22.43 | -2.15 | 1.29 | -0.55 |
| EV to Sales | 0.12 | 0.22 | 0.08 | -0.18 | 0.16 |
| EV to Free Cash Flow | 1.35 | 2.11 | -1.53 | -2.10 | -1.45 |
| EV to Operating Cash Flow | 1.30 | 2.05 | -1.68 | -1.94 | -1.66 |
| Tangible Book Value Per Share | 3.74 | 4.23 | 3.64 | 4.20 | 7.78 |
| Shareholders’ Equity Per Share | 3.73 | 4.22 | 3.63 | 4.19 | 7.75 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.01 | 0.22 | -0.01 | 0.00 | -0.00 |
| Revenue Per Share | 44.60 | 38.18 | 26.45 | 19.42 | 10.73 |
| Net Income Per Share | -1.69 | 0.11 | -1.22 | -2.85 | -3.20 |
| Tax Burden | 1.01 | 0.76 | 1.01 | 0.99 | 1.00 |
| Interest Burden | 1.04 | 0.58 | 1.10 | 1.04 | 1.01 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.18 | 0.00 | 0.24 | 0.34 | 0.14 |
| Stock-Based Compensation to Revenue | 0.01 | 0.01 | 0.03 | 0.03 | 0.04 |
| Income Quality | -2.47 | 37.45 | 1.01 | -0.62 | 0.32 |
Currency in USD

